Rephonic
Artwork for BioCentury This Week

BioCentury This Week

BioCentury
Inflation Reduction Act
Mergers and Acquisitions
Schizophrenia
Alzheimer's Disease
FDA
Biotech
Abbvie
J.P. Morgan Healthcare Conference
Arnold Ventures
U.S. Biotech Ecosystem
Chinese Biotech
CAR T Cell Therapies
CAR T
Janet Woodcock
Singapore
Antibody Drug Conjugates
Psychedelics
China
Sickle Cell Disease
Obesity

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

PublishesTwice weeklyEpisodes336Founded5 years ago
Number of ListenersCategories
BusinessLife SciencesScience

Listen to this Podcast

Artwork for BioCentury This Week

Latest Episodes

Biotech’s fourth quarter began with a familiar feeling, with indicators pointing toward an improving public market even as political and regulatory uncertainty has buysiders reluctant to say industry has returned to sustainable growth. On the latest ... more

The short-term consequences for Pfizer from its “most favored nation” drug pricing deal with the White House are negligible, but the long-term effects on the industry could be profound and permanent.

On the latest BioCentury This Week podcast, BioCe... more

YouTube

Genmab's $8 billion acquisition of multispecifics company Merus is the Danish biotech’s largest step toward marketing its own pipeline. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss the evolution of Genmab, which, for many... more

YouTube

AI is bringing sweeping changes to drug development, from how targets are discovered to optimizing clinical trials to maximize an asset’s chance for success. On a special edition of the BioCentury This Week podcast, IQVIA’s Greg Lever joins BioCentur... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Greg Lever
Director of AI Solutions Delivery at IQVIA
IQVIA
Episode: Ep. 323 - Agentic AI: From New Targets to the Clinic
James Sabry
EVP and Chief Business Officer
BioMarin Pharmaceutical
Episode: Ep. 322 - Takeaways from BioCentury Grand Rounds Europe
Michelle Jones
Chief Operating Officer
Astex Pharmaceuticals
Episode: Ep. 322 - Takeaways from BioCentury Grand Rounds Europe
Simone Fishburne
Editor-in-Chief at BioCentury
BioCentury
Episode: Ep. 315 - China Speed: Data, Deals, First in Class
Franck Le Deu
Senior Partner at McKinsey, co-leads Asia healthcare practice
McKinsey
Episode: Ep. 315 - China Speed: Data, Deals, First in Class
Mike Patten
Chief Strategy Officer at Harbor Biomed, formerly head of Equity and Venture Capital at BMS
Harbor Biomed
Episode: Ep. 315 - China Speed: Data, Deals, First in Class
Ji Li
Former top BD executive at biopharmas, now a consultant on cross-border deals
B1
Episode: Ep. 315 - China Speed: Data, Deals, First in Class
Josh Berlin
Head of BD for BioCentury and VP Editor-in-Chief
BioCentury
Episode: Ep. 315 - China Speed: Data, Deals, First in Class
Meg Hooton
President of IQVIA Biotech
IQVIA Biotech
Episode: Ep. 312 - Biotech Progress Report

Hosts

Jeff Cranmer
Executive editor and host, bringing expertise in the biotech space.
Stephen Hansen
Director of BioPharm Intelligence, focusing on insights in biopharma.

Reviews

4.8 out of 5 stars from 71 ratings
  • terrific summaries capturing the news in this fast-moving space

    LOVE this weekly look at what is happening in biotech, both deep dives into the science itself plus the regulatory/legislative challenges and more. All the regulars are deeply knowledgeable and Jeff Cranmer’s levity as host makes the pod enjoyable and digestible--you really do feel like you have a seat at their editorial meetings. GREAT recaps of the news and in ~30 min or less, I look forward to listening each week!

    Apple Podcasts
    5
    Ios9 problem
    United Statesa year ago
  • Great insights and wisdom!

    Awesome helps me and my team navigate efficiently

    Apple Podcasts
    5
    Surfrider182
    United Statesa year ago
  • Simone Fishburn!!!!

    Simone Fishburn is so well spoken and such a tremendous host. Need more of her in our lives !!

    Apple Podcasts
    5
    Pretty Kitty 2
    United States5 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners praise the insightful analysis of current biotech trends and regulatory landscapes.
The interviews with industry experts are often highlighted for their depth and relevance.
Many comments reflect appreciation for the engaging style and clarity of complex topics.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Ep. 314 - Prasad, Lilly Obesity, Acadia & Biosecure
Q: How is Acadia managing its comeback?
Acadia is pivoting toward rare diseases and modernizing its approach, building out its management team and diversifying its pipeline to reduce risk.
Ep. 314 - Prasad, Lilly Obesity, Acadia & Biosecure
Q: What are the implications of the recent Lilly obesity data?
The data indicates Lilly may not meet high investor expectations, impacting their market cap heavily. It suggests a challenging competitive landscape for obesity treatment.
Ep. 312 - Biotech Progress Report
Q: What are you seeing in terms of phase two success rates for emerging biopharma companies?
Phase two success rates have hovered around 30%, indicating high clinical development costs and long timelines from patent filing to patient availability, highlighting the need for improved decision-making processes.
Ep. 312 - Biotech Progress Report
Q: What state do you see emerging biopharma companies in now and what do they need to do to get back on track?
Meg Hooton defines emerging biopharma companies as those with less than $200 million in R&D spending per year, highlighting their significance in driving niche innovations and their increasing share of early phase trials.
Ep. 310 - Sarepta & What's Next for Gene Therapy. Plus: Leading FDA's CDER
Q: What do we know about George Tidmarsh, the newly appointed head of CDER?
Tidmarsh has a strong background in biopharma and pediatric oncology and has expressed anti-establishment views on previous FDA actions.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioCentury This Week

What is BioCentury This Week about and what kind of topics does it cover?

Focused on the evolving biotech landscape, this podcast offers insights into industry trends, regulatory challenges, and investment opportunities. It features discussions on significant developments involving leading biopharma companies, emerging technologies, and shifts in market dynamics. The content is enriched by expert interviews that provide a deeper understanding of complex scientific and regulatory landscapes, making it a vital resource for investors, executives, and professionals in the biotech field. Notably, the engaging format combines both analytical content and accessible explanations, catering to a broad audience interested in biotechnology and life sciences.

Where can I find podcast stats for BioCentury This Week?

Rephonic provides a wide range of podcast stats for BioCentury This Week. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioCentury This Week and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioCentury This Week get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioCentury This Week, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioCentury This Week?

Rephonic provides comprehensive predictive audience data for BioCentury This Week, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioCentury This Week have?

To see how many followers or subscribers BioCentury This Week has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioCentury This Week?

These podcasts share a similar audience with BioCentury This Week:

1. Biotech Hangout
2. The Readout Loud
3. The BioCentury Show
4. Business Of Biotech
5. Biotech 2050 Podcast

How many episodes of BioCentury This Week are there?

BioCentury This Week launched 5 years ago and published 336 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioCentury This Week?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioCentury This Week?

Rephonic pulls ratings and reviews for BioCentury This Week from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioCentury This Week?

Rephonic provides full transcripts for episodes of BioCentury This Week. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioCentury This Week?

Recent guests on BioCentury This Week include:

1. Greg Lever
2. James Sabry
3. Michelle Jones
4. Simone Fishburne
5. Franck Le Deu
6. Mike Patten
7. Ji Li
8. Josh Berlin

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days